In a published statement on the Facebook page of the Food and Drugs Authority (FDA) was a caution to the general public especially citizens in the Northern Region.
As part of it’s market surveillance activities, the entity came across a falsified anti-malaria drug called COMBIART.
The (Artemether/Lumefantrine 20/120) is now in the market, dangerously it does not contain these two active pharmaceutical ingredients after trials but abysmally it’s written on the label as part of it’s active ingredients.
That is why the FDA is cautioning the general public to not patronize this COMBIART anti-malaria drug.
Details of the drug are as follows:
Batch number: 7225119
manufactory date: 03/2021
expiry date: 02/2024
manufacturers: Strides Arcolab Ltd
NAFDAC Registration: A4-6700